首页> 美国卫生研究院文献>Clinical and Experimental Immunology >Surfactant protein D inhibits lipopolysaccharide-induced monocyte chemoattractant protein-1 expression in human renal tubular epithelial cells: implication for tubulointerstitial fibrosis
【2h】

Surfactant protein D inhibits lipopolysaccharide-induced monocyte chemoattractant protein-1 expression in human renal tubular epithelial cells: implication for tubulointerstitial fibrosis

机译:表面活性剂蛋白D抑制人肾小管上皮细胞中脂多糖诱导的单核细胞趋化蛋白-1的表达:对肾小管间质纤维化的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Surfactant protein D (SP-D), a member of the C-type lectin (collectin) protein family, plays a critical role in innate host defence against various microbial pathogens and in the modulation of inflammatory responses in the lung. However, little is known about its expression and biological function in the kidney. In this work, we studied SP-D expression in human kidney and cultured human renal proximal tubular epithelial cells (HK-2), and examined the effect of SP-D on proinflammatory cytokine production after lipopolysaccharide (LPS) stimulus. We observed the expression of both SP-D mRNA and protein in human kidney and in-vitro HK-2 cells by immunohistochemistry, Western blot analysis, reverse transcription–polymerase chain reaction (RT–PCR) and real-time PCR. To explore the potential role of SP-D in the pathogenesis of tubulointerstitial fibrosis in kidney infection, we examined the production of monocyte chemoattractant protein-1 (MCP-1) in HK-2 cells after LPS treatment. Results showed that the level of MCP-1 in the conditioned medium increased significantly when HK-2 cells were cultured with LPS (>0·1 µg/ml) for 8 h. Of interest, LPS treatment inhibited SP-D expression in HK-2 cells. Furthermore, over-expression of SP-D reduced significantly the LPS-induced expression of MCP-1 in transfected cells. These findings suggest that SP-D in the kidney functions as an anti-inflammatory factor in renal tubular epithelial cells and may modulate tubulointerstitial fibrosis in kidney.
机译:表面活性蛋白D(SP-D)是C型凝集素(集合蛋白)蛋白家族的成员,在天然宿主抵抗各种微生物病原体和调节肺部炎症反应中起着关键作用。然而,对其在肾脏中的表达和生物学功能了解甚少。在这项工作中,我们研究了SP-D在人肾和培养的人肾近端肾小管上皮细胞(HK-2)中的表达,并研究了SP-D对脂多糖(LPS)刺激后促炎性细胞因子产生的影响。我们通过免疫组织化学,蛋白质印迹分析,逆转录聚合酶链反应(RT-PCR)和实时PCR观察了人肾脏和体外HK-2细胞中SP-D mRNA和蛋白的表达。为了探讨SP-D在肾感染的肾小管间质纤维化发病机理中的潜在作用,我们检查了LPS处理后HK-2细胞中单核细胞趋化蛋白-1(MCP-1)的产生。结果显示,当HK-2细胞用LPS(> 0·1 µg / ml)培养8 h时,条件培养基中MCP-1的含量显着增加。有趣的是,LPS处理可抑制HK-2细胞中SP-D的表达。此外,SP-D的过表达显着降低了LPS诱导的MCP-1在转染细胞中的表达。这些发现表明,肾脏中的SP-D在肾小管上皮细胞中起抗炎因子的作用,并可能调节肾脏中的肾小管间质纤维化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号